Yıldız Dilbade Ekinci

9PUBLICATIONS
11CO-AUTHORS
PharmacogenomicsInfant and child healthNeonatologyOptical technologyOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 08, 2023
Neurodevelopment of patients who received intravitreal bevacizumab or aflibercept for type 1 and aggressive retinopathy of prematurity.

Senay Guven Baysal, Dilbade Yildiz Ekinci, Nilufer Okur

|Jun 06, 2023
A novel marker for predicting type 1 retinopathy of prematurity: C-reactive protein/albumin ratio.

Dilbade Yildiz Ekinci, Handan Bezirganoglu, Nilufer Okur

|Sep 29, 2021
Evaluation of the relationship between HbA1c level and retina choroidal thickness in patients with gestational diabetes mellitus.

Bekir Kahveci, Yıldız Dilbade Ekinci

|Aug 25, 2021
The possible effect of pentoxifylline on development and severity of retinopathy of prematurity.

İbrahim Mert Erbaş, Merih Çetinkaya, Dilbade Yıldız Ekinci

|Jul 14, 2020
WHAT IS THE INCIDENCE OF RETINOPATHY OF PREMATURITY (ROP) IN 'BIG' BABIES?: RESULTS OF A RETROSPECTIVE MULTICENTER STUDY.

Dilbade Yildiz Ekinci, Adem Ugurlu, Nurdan Gamze Tasli

Pageof 2